Urinary stones in HIV-1-positive patients treated with indinavir.
Daudon
M
M
Estépa
L
L
Viard
J P
JP
Joly
D
D
Jungers
P
P
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D005260:Female; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006679:HIV Seropositivity / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D019469:Indinavir / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D014545:Urinary Calculi / Q000139:chemically induced* / Q000737:chemistry / Q000473:pathology
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir